Influence of nociceptin(1-17) fragments and its tyrosine-substituted derivative on morphine-withdrawal signs in rats

Neuropeptides

Volumn 38, Issue 5, 2004, Pages 277-282

  Kotlinska, Jolanta ^a   Dylag, Tomasz ^b   Rafalski, Piotr ^a   Talarek, Sylwia ^a   Kosior, Maria ^b   Silberring, Jerzy ^b,c  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Metabolism; Morphine dependence; Morphine withdrawal syndrome; Nociceptin; Rat

Indexed keywords

NALOXONE; NOCICEPTIN; PHENYLALANINE;

ABSTINENCE; AMINO TERMINAL SEQUENCE; ARTICLE; ATTENUATION; CONTROLLED STUDY; DRUG WITHDRAWAL; LOCOMOTION; MALE; METABOLISM; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; WITHDRAWAL SYNDROME;

ANIMALS; MALE; MORPHINE; MORPHINE DEPENDENCE; MOTOR ACTIVITY; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID PEPTIDES; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, OPIOID; SUBSTANCE WITHDRAWAL SYNDROME; TYROSINE; VASODILATOR AGENTS;

CANIS FAMILIARIS;

EID: 4644251752     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2004.05.001     Document Type: Article

References (39)

1. Ali B., Sharif S., Elkadi A. Sex differences and the effect of gonadectomy on morphine-induced antinociception and dependence in rats and mice. Clin. Exp. Pharmacol. Physiol. 22:1995;342-344
2. Bläsing J., Herz A., Reinhold K., Zieglgänsberger S. Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacology. 33:1973;19-38
3. Calo G., Guerrini R., Rizzi A., Salvadori S., Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br. J. Pharmacol. 129:2000;1261-1283
4. Dahlstrom A., Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. 232(Suppl. 2):1964;1-55
5. Grisel J.E., Mogil J.S., Belknap J.K., Grandy D.K. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. Neuroreport. 7:1996;2125-2129
6. Howes J.F. A simple, reliable method for predicting the physical dependence liability of narcotic antagonist analgesic in rats. Pharmacol. Biochem. Behav. 14:1981;689-692
7. Jaw S.P., Makimura M., Hoskins B., Ho I.K. Effects of nor-binaltorphimine on butorphanol dependence. Eur. J. Pharmacol. 239:1993;133-140
8. Johnson E.E., Lambert D.G. Molecular pharmacology of the opioid/nociceptin system. Curr. Anaesthesia Cr. Care. 13:2002;303-312
9. King M., Chang A., Pasternak G.W. Functional blockade of opioid analgesia by orphanin FQ/nociceptin. Biochem. Pharmacol. 55:1998;1537-1540
10. Koob G.F., Maldonado R., Stinus L. Neuronal substrates of opiate withdrawal. Trends Neurosci. 15:1992;186-191
11. Kotlinska J., Suder P., Legowska A., Rolka K., Silberring J. Orphanin FQ/nociceptin inhibits morphine withdrawal. Life Sci. 66:2000;PL119-PL23
12. Kotlinska J., Suder P., Sciubisz A., Legowska A., Eilmes J., Rolka K., Silberring J. C-terminal glycine is crucial for hyperalgesic activity of nociceptin/orphanin FQ-(1-6). Eur. J. Pharmacol. 419:2001;33-37
13. Kotlinska J., Wichmann J., Rafalski P., Talarek S., Dylag T., Silberring J. Non-peptidergic receptor agonist inhibits morphine antinociception but does not influence morphine dependence. Neuroreport. 14:2003;601-604
14. Malin D.H., Lake J.R., Moon W.D., Moy D., Montellano A.L., Moy E., Campbell T.D., Bell M.V., Bryant D., Harrison L.M., Grandy D.K. Nociceptin/orphanin FQ (N/OFQ) induces quasi-morphine abstinence syndrome in the rat. Psychopharmacology. 151:2000;344-350
15. Maldonado R., Stinus L., Gold L.H., Koob G.F. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261:1992;669-677
16. Marshall J., Graham-Smith D.G. Evidence against a role of brain5-hydroxytryptamine in the development of physical dependence upon morphine in mice. J. Pharmacol. Exp. Ther. 173:1971;634-641
17. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535
18. Meunier J., Mouledous L., Topham C.M. The nociceptin (ORL1) receptor: molecular cloning and functional architecture. Peptides. 21:2000;893-900
19. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75:1996;333-337
20. Mogil J.S., Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev. 53:2001;381-415
21. Mollereau C., Simons M.J., Soularue P., Linears F., Vassart G., Meunier J.C., Parmentier M. Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc. Natl. Acad. Sci. USA. 93:1996;8666-8670
22. Montiel J.L., Cornille F., Roques B.P., Noble F. Nociceptin/orphanin FQ metabolism: role of aminopeptidase and endopeptidase 24.15. J. Neurochem. 68:1997;354-361
23. Moran T.D., Abdulla F.A., Smith P.A. Cellular neurophysiological actions of nociceptin/orphanin FQ. Peptides. 21:2000;969-976
24. Nothacker H.P., Reinscheid R.K., Mansour A., Henningsen R.A., Ardati A., Monsma F.J., Watson S.J., Civelli O. Primary structure and tissue distribution of the orphanin FQ precursor. Proc. Natl. Acad. Sci. USA. 93:1996;8677-8682
25. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1982;Academic Press, Sydney
26. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J. Jr., Civelli O. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science. 270:1995;792-794
27. Sbrenna S., Marti M., Morari M., Calo' G., Guerrini R., Beani L., Bianchi C. Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin. Br. J. Pharmacol. 130:2000;425-433
28. Schulz S., Schreff M., Nuss D., Gramsch C., Hollt V. Nociceptin/orphanin FQ and opioid peptides show overlapping distribution but not co-localization in pain-modulatory brain regions. Neuroreport. 7:1996;3021-3025
29. Schwyzer R. ACTH: a short introductory review. Ann. NY Acad. Sci. 297:1977;3-26
30. Siniscalchi A., Rodi D., Beani L., Bianchi C. Inhibitory effect of nociceptin on [3H]-5-HT release from rat cerebral cortex slices. Br. J. Pharmacol. 128:1999;119-123
31. Suder P., Kotlinska J., Smoluch M.T., Sallberg M., Silberring J. Metabolic fate of nociceptin/orphanin FQ in the rat spinal cord and biological activity of its released fragment. Peptides. 20:1999;239-247
32. Tian J.H., Xu W., Fang Y., Grisel J.E., Mogil J.S., Grandy D.K., Han J.-S. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of rat. Br. J. Pharmacol. 120:1997;676-680
33. Tian J.H., Xu W., Zhang W., Fang Y., Grisel J.E., Mogil J.S., Grandy D.K., Han J.S. Involvement of endogenous orphanin FQ in electroacupuncture- induced analgesia. Neuroreport. 8:1997;497-500
34. Varani K., Rizzi A., Calo G., Bigoni R., Toth G., Guerrini R., Gessi S., Salvadori S., Borea P.A., Regoli D. Pharmacology of (Tyr1)nociceptin analogs: receptor binding and bioassay studies. Naunyn Schmiedebergs Arch. Pharmacol. 360:1999;270-277
35. Way E.L., Loh H.H., Shen E. Simultaneous quantitative assessment of morphine tolerance and physical dependence. J. Pharmacol. Exp. Ther. 167:1969;1-8
36. Wei E. Assessment of precipitated abstinence in morphine-dependent rats. Psychopharmacology. 28:1973;35-44
37. Xu X.J., Hao J.X., Wiesenfeld-Hallin Z. Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. Neuroreport. 7:1996;2092-2094
38. Yap C., Taylor D. Involvement of 5-HT2 receptors in the wet dog shake behavior induced by 5-hydroxytryptophan in the rat. Neuropharmacology. 22:1983;801-804
39. Zhu C.B., Cao X.D., Xu S.F., Wu G.C. Orphanin FQ potentiates formalin-induced pain behavior and antagonizes morphine analgesia in rats. Neurosci. Lett. 235:1997;37-40